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Methods: Two groups of Wistar rats were examined: rats
subjected to common bile duct ligation (CBDL) and rats
subjected to a sham operation. Bacterial clearance, organ
distribution and phagocytic function of Kupffer cells were
examined.
Results: In this study, clearance of Escherichia coli from the
peripheral blood in CBDL rats was decreased signiﬁcantly
compared with that in sham-operated rats. A signiﬁcant
decrease in E. coli trapped in the liver was observed in CBDL
rats compared with sham-operated rats. Phagocytic activity
and superoxide production of Kupffer cells isolated from
CBDL rats were signiﬁcantly lower than in sham-operated
rats.
Conclusion: The results suggest that susceptibility to
infection in obstructive jaundice is due to impaired
phagocytic function of Kupffer cells.
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Background and Aims: Hepatitis E is the most important
cause of acute viral hepatitis in adults throughout Asia, the
Middle East and Africa where the sanitation conditions are
usually substandard. The aim of this study was to investigate
the genetic characterization of hepatitis E virus (HEV) and
its correlation with pathogenicity in patients with or without
chronic liver disease and also the phylogenetic relationship
between human and swine HEV to assess potential risky
factor for sporadic hepatitis E.
Methods: 62 serum samples of patients with acute hepatitis
E were collected, including 23 cases coinfected with
hepatitis B virus (HBV). The clinical information (age,
sex, complication, mortality, markers of liver function)
of patients with liver failure were recorded. Anti-HEV
detection and partial HEV RNA ampliﬁcation were performed
by enzyme immunoassays (EIA) and reverse transcription-
nested polymerase chain reaction (RT-nPCR) method
respectively, PCR products were sequenced. The isolated
human HEV sequences were analyzed phylogenetically.
Results: 10 of 62 cases suffered from liver failure. The
positive rate of HEV RNA in serum were 21.0% (13/62),
including 4 patients with liver failure. All 13 isolates shared
82.1%-98.0% nucleotide homology with each other and had
identities of 74.7%-81.0%, 75.3%-78.6%, 75.3%-80.0% and
82.1%-96.1% with the corresponding regions of genotypes
1 4 HEV respectively. One human HEV strain (GS-NJ-12)
shared 100% nucleotide identity with the swine HEV strain
named swIM6 43.
Conclusions: This study provides further evidence
supporting the possibility of zoonotic transmission of HEV
from swine to human, genotype 4 HEV can result in acute
liver failure and acute-on-chronic failure.
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Background: The abnormality of IGF-II expressions involved
in the formation and development of HCC. However,
their molecular mechanism and expression rule remains
not too clear. In the present study, we investigated the
levels of IGF-II expression in cancerous, paracancerous,
noncancerous tissues, and circulating blood in HCC patients,
and the clinicopathological features of IGF-II abnormality,
and analyze the effect of speciﬁc siRNA-mediated inhibition
of IGF-II on apoptosis of human HepG2 cells.
Methods: The levels of circulating IGF-II in patients with
liver diseases and 30 healthy individuals were detected
by ELISA. IGF-IIsiRNA was used to down-regulate IGF-II
expression in human HepG2 cells; RT-PCR and ELISA were
used to examine IGF-II expression; Annexin V-FLUOS/PI was
used to test cell apoptosis.
Results: The expression of IGF-II in peripheral blood of
HCC patients was signiﬁcantly more than patients with non-
liver tumors, acute or chronic hepatitis, liver cirrhosis, and
normal subjects (P = 0.000). The overexpression of IGF-II in
the cancerous group was associated with HBV infection.
At 72 h after IGF-IIsiRNA transfection, IGF-II expression in
the 150 nM group in the HepG2 cells reduced 63% at mRNA
and 44.5% at protein levels. The down-regulation of IGF-II
expression was depended on the dose of IGF-IIsiRNA and the
action time after speciﬁc siRNA transfection. Interestingly,
the apoptosis index of the HepG2 cells increased with IGF-
II inhibition, and the down-regulation of IGF-II sensitized
HepG2 cells to adriamycin.
Conclusion: The abnormal activation of hepatic IGF-II is
closely associated with the occurrence and development
of HCC, and IGF-II inhibition mediated by speciﬁc siRNA
promotes HepG2 cells apoptosis. Therefore IGF-II is a
potential target for HCC gene therapy.
PP-080 Investigation on MMP-9 concentration in sera of
people infected by Helicobacter pylori
G.H. Ettehad1 *, M. Amani1, N. Parastar1. 1Faculty of
Medicine, Ardabil University of Medical Science, Ardabil,
Iran
Objectives: Helicobacter Pylori (HP), as a gram negative
bacterium colonizing in the gastric mucosa, induces
gastrodeudenal complications varying from mild gastritis
to gastric malignancies. mmp-9, an enzyme with protease
activity, plays key role in cancer induction and metathesis.
Regarding to high incidence of gastric cancer in Ardabil
province, the present study was conducted with the
following major question whether the increase of serum
level of mmp-9 can be seen before induction of cancer
by H.P.
Methods: Serum and stool specimens together were
obtained from 200 apparently healthy individuals. Samples
were stored at 70ºC until ELISA experiments. ELISA kits
were used to assess H. Pylori Ag in stools and serum
concentration of mmp-9.
Results: Obtained results showed increase of serum level
of mmp-9 in H.P infected person in comparison to healthy
ones.
Discussion: Albeit our results show increase in serum level
of mmp-9 in infected persons but this is not signiﬁcant.
Previous studies showed signiﬁcant increase in mmp-9
concentration in biopsy samples prepared from H.P. infected
persons. This controversy may arise from differences in
studied population, variety of H.P., the manner of sampling
and detection of H.P. infection. We suggest making a similar
investigation with special regards to these factors.
